Albany, N.Y. — New York is seeking to secure $2 billion in restitution from opioid manufacturers, distributors and pharmacy benefit managers that the state Department of Financial Services determined has been overcharged over the last decade. The overpayment is due to costs associated with misrepresentation of the safety and efficacy of opioids, according to the governor’s office, which in turn “has